Raia Drogasil S.A.
RADLY
$3.56
$0.2597.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.91B | 1.72B | 1.73B | 1.80B | 1.86B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.91B | 1.72B | 1.73B | 1.80B | 1.86B |
| Cost of Revenue | 1.35B | 1.22B | 1.21B | 1.27B | 1.30B |
| Gross Profit | 564.86M | 492.55M | 511.08M | 535.78M | 562.60M |
| SG&A Expenses | 437.91M | 411.48M | 421.25M | 420.54M | 435.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 166.80K | -6.52M | 6.16M | 4.66M | 1.45M |
| Total Operating Expenses | 1.78B | 1.63B | 1.64B | 1.69B | 1.73B |
| Operating Income | 126.78M | 87.59M | 83.66M | 110.59M | 125.96M |
| Income Before Tax | 70.57M | 34.23M | 47.71M | 79.51M | 79.80M |
| Income Tax Expenses | 3.00M | 6.03M | -11.84M | 18.35M | 16.74M |
| Earnings from Continuing Operations | 67.58M | 28.20M | 59.55M | 61.16M | 63.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.58M | -190.00K | 20.70K | -739.90K | -391.60K |
| Net Income | 66.00M | 28.01M | 59.57M | 60.42M | 62.67M |
| EBIT | 126.78M | 87.59M | 83.66M | 110.59M | 125.96M |
| EBITDA | 162.56M | 119.67M | 115.04M | 142.53M | 159.14M |
| EPS Basic | 0.04 | 0.02 | 0.04 | 0.04 | 0.02 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.02 | 0.03 | 0.02 |
| EPS Diluted | 0.04 | 0.02 | 0.04 | 0.04 | 0.02 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.02 | 0.03 | 0.02 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 1.65B | 1.65B | 2.87B |
| Average Diluted Shares Outstanding | 1.66B | 1.65B | 1.65B | 1.66B | 2.87B |
| Dividend Per Share | -- | 0.01 | -- | 0.02 | -- |
| Payout Ratio | 82.42% | 0.06% | 67.74% | 0.33% | 72.67% |